Puma Biotechnology, Inc.
PBYI
$3.01
-$0.03-0.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.59% | -4.98% | 548.60% | 5.94% | -139.25% |
| Total Depreciation and Amortization | -1.58% | -1.29% | -1.03% | 0.38% | 0.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.36% | -32.50% | 6.76% | -24.45% | -11.15% |
| Change in Net Operating Assets | 44.29% | 44.27% | -1,941.74% | -92.80% | 242.34% |
| Cash from Operations | -76.86% | 41.39% | 974.78% | -90.87% | 7.57% |
| Capital Expenditure | -281.25% | 20.00% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 169.10% | -925.81% | -61.41% | 103.79% | -134.83% |
| Cash from Investing | 165.99% | -995.75% | -63.16% | 103.68% | -133.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.45% | 0.90% | -0.45% | -- | -- |
| Cash from Financing | -0.01% | -1.32% | 1.31% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -416.41% | 1,615.79% | 101.19% | -22.57% | -442.84% |